ASGCT 2024: Gene Therapy Post-Conference Report

Join us as we explore the advancements presented at the 2024 ASGCT Annual Meeting. Our analyst team has screened the abstracts presented and identified 177 abstracts (45 clinical, 128 preclinical, and 4 with preclinical and clinical data) associated with trial or drug records on Beacon Gene Therapy, providing insights and comprehensive coverage through our exclusive planner and report. Download today and stay informed about the latest developments in the space.

ASGCT 2024: Gene Therapy Abstract Highlights

Our Post-Conference Report offers an in-depth analysis and summary of the 177 gene therapy-related abstracts presented at the 2024 ASGCT Annual Meeting. This report is an essential resource for staying updated on the latest developments and innovations in the field.

Highlights include:

  • Analysis of the abstracts by the delivery system being investigated, top 10 diseases, and trial phase.
  • A comprehensive summary of each abstract, including trial sponsor, delivery system, trial results, and safety outcomes.
  • Convenient links to corresponding drug and trial pages on Beacon ensure easy access to further information.

We hope you find this report useful and insightful. We are as excited as we are to see the latest developments in gene therapy.

You May Also Be Interested In…

Learn More About Gene Therapy

What is Beacon Gene Therapy?
  • The Most Comprehensive Way to Search the Gene Therapy Development Landscape: Unique search ontologies based on Gene Therapy drug and trial characteristics
  • Market Leading Approach to Gene Therapy Preclinical & Clinical Data Curation: Manual curation of key Gene Therapy research and development data points by Gene Therapy research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Gene Therapy company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Gene Therapy Request a Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search